Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03070030 11-HEPE cPLA2i 1.0 BCD110605C28 0.164 pmol/ml medium
LMFA03070030 11-HEPE cPLA2i 1.0 BCD110605C30 0.174 pmol/ml medium
LMFA03070030 11-HEPE cPLA2i 1.0 BCD110605C29 0.164 pmol/ml medium
LMFA03070030 11-HEPE cPLA2i 20.0 BCD110605C64 0.315 pmol/ml medium
LMFA03070030 11-HEPE cPLA2i 20.0 BCD110605C66 0.429 pmol/ml medium
LMFA03070030 11-HEPE cPLA2i 20.0 BCD110605C65 0.287 pmol/ml medium
LMFA03070030 11-HEPE PLDi 1.0 BCD110605C16 0.184 pmol/ml medium
LMFA03070030 11-HEPE PLDi 1.0 BCD110605C17 0.177 pmol/ml medium
LMFA03070030 11-HEPE PLDi 1.0 BCD110605C18 0.156 pmol/ml medium
LMFA03070030 11-HEPE PLDi 20.0 BCD110605C54 0.294 pmol/ml medium
LMFA03070030 11-HEPE PLDi 20.0 BCD110605C52 0.3 pmol/ml medium
LMFA03070030 11-HEPE PLDi 20.0 BCD110605C53 0.303 pmol/ml medium
LMFA03070030 11-HEPE KDO+cPLA2i 1.0 BCD110605C32 0.168 pmol/ml medium
LMFA03070030 11-HEPE KDO+cPLA2i 1.0 BCD110605C31 0.182 pmol/ml medium
LMFA03070030 11-HEPE KDO+cPLA2i 1.0 BCD110605C33 0.162 pmol/ml medium
LMFA03070030 11-HEPE KDO+cPLA2i 20.0 BCD110605C68 0.232 pmol/ml medium
LMFA03070030 11-HEPE KDO+cPLA2i 20.0 BCD110605C69 0.34 pmol/ml medium
LMFA03070030 11-HEPE KDO+cPLA2i 20.0 BCD110605C67 0.295 pmol/ml medium
LMFA03070030 11-HEPE KDO+PLDi 1.0 BCD110605C19 0.212 pmol/ml medium
LMFA03070030 11-HEPE KDO+PLDi 1.0 BCD110605C20 0.175 pmol/ml medium
LMFA03070030 11-HEPE KDO+PLDi 1.0 BCD110605C21 0.143 pmol/ml medium
LMFA03070030 11-HEPE KDO+PLDi 20.0 BCD110605C56 0.223 pmol/ml medium
LMFA03070030 11-HEPE KDO+PLDi 20.0 BCD110605C57 0.249 pmol/ml medium
LMFA03070030 11-HEPE KDO+PLDi 20.0 BCD110605C55 0.211 pmol/ml medium
LMFA03070030 11-HEPE KDO+ATP+cPLA2i 1.0 BCD110605C37 0.182 pmol/ml medium
LMFA03070030 11-HEPE KDO+ATP+cPLA2i 1.0 BCD110605C38 0.151 pmol/ml medium
LMFA03070030 11-HEPE KDO+ATP+cPLA2i 1.0 BCD110605C39 0.129 pmol/ml medium
LMFA03070030 11-HEPE KDO+ATP+cPLA2i 20.0 BCD110605C74 0.218 pmol/ml medium
LMFA03070030 11-HEPE KDO+ATP+cPLA2i 20.0 BCD110605C75 0.269 pmol/ml medium
LMFA03070030 11-HEPE KDO+ATP+cPLA2i 20.0 BCD110605C73 0.301 pmol/ml medium
LMFA03070030 11-HEPE KDO+ATP+PLDi 1.0 BCD110605C25 0.155 pmol/ml medium
LMFA03070030 11-HEPE KDO+ATP+PLDi 1.0 BCD110605C27 0.151 pmol/ml medium
LMFA03070030 11-HEPE KDO+ATP+PLDi 1.0 BCD110605C26 0.166 pmol/ml medium
LMFA03070030 11-HEPE KDO+ATP+PLDi 20.0 BCD110605C61 0.234 pmol/ml medium
LMFA03070030 11-HEPE KDO+ATP+PLDi 20.0 BCD110605C62 0.227 pmol/ml medium
LMFA03070030 11-HEPE KDO+ATP+PLDi 20.0 BCD110605C63 0.186 pmol/ml medium
LMFA03070030 11-HEPE KDO + ATP 1.0 BCD110605C15 0.133 pmol/ml medium
LMFA03070030 11-HEPE KDO + ATP 1.0 BCD110605C14 0.159 pmol/ml medium
LMFA03070030 11-HEPE KDO + ATP 1.0 BCD110605C13 0.169 pmol/ml medium
LMFA03070030 11-HEPE KDO + ATP 20.0 BCD110605C49 0.213 pmol/ml medium
LMFA03070030 11-HEPE KDO + ATP 20.0 BCD110605C50 0.213 pmol/ml medium
LMFA03070030 11-HEPE KDO + ATP 20.0 BCD110605C51 0.248 pmol/ml medium
LMFA03070030 11-HEPE KDO 1.0 BCD110605C08 0.174 pmol/ml medium
LMFA03070030 11-HEPE KDO 1.0 BCD110605C07 0.183 pmol/ml medium
LMFA03070030 11-HEPE KDO 1.0 BCD110605C09 0.155 pmol/ml medium
LMFA03070030 11-HEPE KDO 20.0 BCD110605C45 0.211 pmol/ml medium
LMFA03070030 11-HEPE KDO 20.0 BCD110605C44 0.284 pmol/ml medium
LMFA03070030 11-HEPE KDO 20.0 BCD110605C43 0.255 pmol/ml medium
LMFA03070030 11-HEPE C 0.0 BCD110605C03 0.172 pmol/ml medium
LMFA03070030 11-HEPE C 0.0 BCD110605C01 0.17 pmol/ml medium